Showing results (711-720 of 1,011) with videos related to

Sort By:
Pageof 102
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
The International Journal of Behavioral Nutrition and Physical Activity|June 25, 2020
Contribution of major food companies and their products to household dietary sodium purchases in AustraliaDaisy H Coyle, Maria Shahid, Elizabeth K Dunford, et al.
Diabetes Care|December 4, 2014
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetesBruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.
Diabetes, Obesity & Metabolism|February 15, 2022
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trialJennifer Y Barraclough, Jie Yu, Gemma A Figtree, et al.
Sleep|February 12, 2015
The Sleep Apnea cardioVascular Endpoints (SAVE) Trial: Rationale, Ethics, Design, and ProgressNick A Antic, Emma Heeley, Craig S Anderson, et al.
The American Journal of Clinical Nutrition|March 30, 2021
Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trialJie Yu, Sudhir Raj Thout, Qiang Li, et al.
Contemporary Clinical Trials|July 23, 2011
IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary careVanessa Selak, C Raina Elley, Sue Crengle, et al.
Nature Medicine|March 27, 2024
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.
Diabetes Care|September 22, 2022
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVASAkihiko Koshino, Meir Schechter, Taha Sen, et al.
The Lancet. Public Health|November 1, 2024
Estimated health benefits, costs, and cost-effectiveness of implementing WHO's sodium benchmarks for packaged foods in India: a modelling studyKathy Trieu, Liping Huang, Leopold N Aminde, et al.
Pageof 102